medline.ch Gastroenterologie Magen-Darm Funktionelle Beschwerden

	Systemic inflammation and malaria co-infection in irritable bowel syndrome: a cross-sectional study of 142 Yemeni patients. BMJ Open Ali NT, Mehdi MAH, Abdullah RS, Gubran ANM, Al-Abd NM, Ali GS, Mohsen Ali H. PMID: 42086258 [PubMed - indexed for MEDLINE]
	Comparative Study on Burden, Features and Determinants of Disorders of Gut-Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Study. United European Gastroenterol J Marasco G, Hod K, Colecchia L, Sperber AD, Palsson OS, Bangdiwala SI, Barbara G. PMID: 42083911 [PubMed - indexed for MEDLINE]
	Insomnia, A Comorbidity to Take Into Account in the Global Management of Patients With Irritable Bowel Syndrome? Neurogastroenterol Motil Albert E, Mikhael-Moussa H, Wuestenberghs F, Leroi AM, Netchitailo M, Gourcerol G, Trindade IA, Desprez C, Melchior C. PMID: 42083791 [PubMed - indexed for MEDLINE]
	Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis. Am J Gastroenterol Lembo AJ, Chey WD, Harris LA, Frazier R, Brenner DM, Chang L, Lacy BE, Edelstein S, Yang Y, Zhao S, Rosenbaum DP. PMID: 42080433 [PubMed - as supplied by publisher]
	Clinical Features and Symptom Burden in Vietnamese Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Single-Center Cross-Sectional Study Using IBS-SSS and IBS-QoL Scores. J Clin Med Nguyen QH, Lam HT, Trinh TTT, Vo TD. PMID: 42074712 [PubMed]
	Recommendations for the Evaluation and Management of Inflammatory Bowel Disease with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus. Gastroenterology Ma C, Ford AC, Hashash JG, Barbara G, Bernstein CN, Brenner DM, Griffiths AM, Keefer L, Long MD, Nurko S, Singh P, Sands BE, Chang L. PMID: 42066865 [PubMed - as supplied by publisher]
	The Management of Irritable Bowel Syndrome: A Position Paper of the Neurogastroenterology and Motility Section of the Israeli Gastroenterology Association. J Clin Gastroenterol Shibli F, Dekel R, Yishai R, Lysy J, Sperber A, Bar N, Baruch R, Frishman S, Nevo Shor A, Hershkovici T, Thurm T, Mari A, Carter D, Brun R, Ishay Y, Dickman R. PMID: 42066057 [PubMed - as supplied by publisher]
	Pathophysiology-driven use of natural products in irritable bowel syndrome: a review. Naunyn Schmiedebergs Arch Pharmacol Mohamed FA, Hassan MM, Aboulmagd YM, Attallah KA, Ghaiad HR, El-Shiekh RA, Fahmy MI. PMID: 42065756 [PubMed - as supplied by publisher]
	Long-term risk of irritable bowel syndrome associated with triglyceride-glucose related indices: a large-scale prospective cohort study. Ther Adv Gastroenterol Liu H, Liu S, Zhang Q, Zhang S, Zhu S, Wu S. PMID: 42065095 [PubMed]
	Online Group Hypnotherapy for Irritable Bowel Syndrome-a Pilot Study. Neurogastroenterol Motil Lövdahl J, Törnblom H, Ringström G, Palsson OS, Simrén M. PMID: 42057428 [PubMed - indexed for MEDLINE]
	Prevalence, clinical significance and predictors of small intestinal bacterial overgrowth and elevated fecal calprotectin in refractory irritable bowel syndrome: Insights from a prospective cross-sectional study. Indian J Gastroenterol Goyal O, Aggarwal A, Goyal MK, Mehta V, Mahajan R, Gupta Y, Singh A, Sood A. PMID: 42053754 [PubMed - as supplied by publisher]
	AN OPEN-LABEL TRIAL OF EFFECTS OF VARENICLINE IN NON-CONSTIPATION IRRITABLE BOWEL SYNDROME AND PAIN. Clin Gastroenterol Hepatol Matar A, Busciglio I, Eckert D, Linden DR, Harmsen WS, Camilleri M. PMID: 42044783 [PubMed - as supplied by publisher]
	Efficacy and safety of Guanylyl cyclase C agonists (linaclotide and plecanatide) in patients with irritable bowel syndrome with constipation: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol Zhou Z, Li Y, Tu Y, He M, Liao D, He Z, Liu Z, Li B, Zhou Z, Ai S. PMID: 42038325 [PubMed]
	Design of Treatment Trials for Disorders of Gut-Brain Interaction. Gastroenterology Sayuk GS, Brenner DM, Carbone F, Knowles SR, Lacy BE, Staudacher HM, Ford AC. PMID: 42031442 [PubMed - indexed for MEDLINE]
	Validation of MENTOR Tool to Describe Bowel Dysfunction in Inpatient Rehabilitation Setting. Top Spinal Cord Inj Rehabil Wilson JR, Alvarenga V, Cowan RE, DeRasmi A, Martinez K, Monden KR, Rankin JW, Rybi, Vives Alvarado JR, Anderson KD. PMID: 42028357 [PubMed - indexed for MEDLINE]
	A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome. Clin Gastroenterol Hepatol Lee A, Rao K, Singh P, Fehlman J, Gao J, Takakura W, Lynett A, Haller E, Ball S, Marand A, Liu A, Shah E, Menees S, Punglia R, Nojkov B, Eswaran S, Baker J, Chey WD, Owyang C, Young V, Hasler WL. PMID: 42025708 [PubMed - as supplied by publisher]
	Identification of LRP8 as a potential therapeutic target for irritable bowel syndrome from the proteomes of plasma and cerebrospinal fluid in a Mendelian randomization study. Rev Esp Enferm Dig Zhuo Y, Zhao L, Li D, Ding Y, Liu N, Wang Y, Liu J, Shen C, Zhang S. PMID: 42024114 [PubMed - as supplied by publisher]
	Childhood Maltreatment and Its Pathways to Irritable Bowel Syndrome in Adulthood: Insights From Sequential Mediation Analysis. Stress Health Peng S, Liu Q, Ni Y, Tao J, Guo L. PMID: 42017339 [PubMed - indexed for MEDLINE]
	Early transanal irrigation in spinal cord injury-related neurogenic bowel dysfunction: preliminary insights. Spinal Cord Ser Cases Frasca G, De Palma L, Megna M, Rosso I, Cocchini L, Medina G, Righi G, Baroni A, Del Popolo G, Bonaccorsi A, Savoca F, Costa A. PMID: 42009662 [PubMed - indexed for MEDLINE]
	Correction: A Cross-Sectional Study on Pediatric Resident Knowledge and Perceptions of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Western Saudi Arabia. Cureus Sukkar GA, Kordi RE, Alahmadi RY. PMID: 42006520 [PubMed]

Artikel 1 - 20 / 9481

Seite 1 von 475



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung